TIDM0Y4Q
RNS Number : 1800S
Willis Towers Watson PLC
06 July 2020
Ap9
APPIX 3
DISCLOSURE FORMS
FORM 8.1(a)&(b)(i)
IRISH TAKEOVER PANEL
DISCLOSURE UNDER RULE 8.1(a) AND (b)(i) OF THE IRISH TAKEOVER
PANEL ACT, 1997, TAKEOVER RULES, 2013
DEALINGS BY OFFERORS, OFFEREES OR PARTIES ACTING IN CONCERT WITH
THEM FOR THEMSELVES OR FOR DISCRETIONARY CLIENTS
1. KEY INFORMATION
Name of person dealing Jaymin B. Patel
(Note 1)
Company dealt in Willis Towers Watson plc
================================
Class of relevant security Ordinary Shares of $0.000304635
to which the dealings each
being disclosed relate
(Note 2)
================================
Date of dealing 10 June 2020
================================
2. INTERESTS AND SHORT POSITIONS
(a) Interests and short positions (following dealing) in the
class of relevant
security dealt in (Note 3)
Long Short
Number (%) Number (%)
============= ====== =========== ======
(1) Relevant securities Ordinary Shares:
4,697 (0.0036%)
===================== ===================
(2) Derivatives (other N/A
than options)
===================== ===================
(3) Options and agreements RSU: 803 (0.0062%)
to purchase/sell
===================== ===================
Total 5,500 (0.0042%)
===================== ===================
(b) Interests and short positions in relevant securities of the
company, other than the class dealt
in (Note 3)
Class of relevant security: Long Short
Number (%) Number (%)
=========== ===== =========== ======
(1) Relevant securities N/A
==================== =====================
N/A
(2) Derivatives (other
than options)
==================== =====================
N/A
(3) Options and agreements
to purchase/sell
==================== =====================
Total N/A
==================== =====================
Ap10
3. DEALINGS (Note 4)
(a) Purchases and sales
Purchase/sale Number of relevant securities Price per unit
(Note 5)
(b) Derivatives transactions (other than options transactions)
Product Nature of transaction Number of relevant Price per
name, (Note 6) securities unit
e.g. CFD (Note 7) (Note 5)
(c) Options transactions in respect of existing relevant securities
(i) Writing, selling, purchasing or varying
Product Writing, Number of Exercise Type, Expiry Option
name, selling, securities price e.g. American, date money paid/received
e.g. call purchasing, to which European per unit
option varying the option etc. (Note 5)
etc. relates (Note
7)
RSU Grant 803 N/A N/A N/A N/A
============= =============== ========= ================ ====== =====================
(ii) Exercising
Product name, Number of securities Exercise price
e.g. call option per unit (Note
5)
(d) Other dealings (including transactions in respect of new
securities) (Note 4)
Nature of transaction Details Price per unit
(Note 8) (if applicable)
(Note 5)
Ap11
4. OTHER INFORMATION
Agreements, arrangements or understandings relating to options
or derivatives
Full details of any agreement, arrangement or understanding
between the person disclosing and
any other person relating to the voting rights of any relevant
securities under any option referred to
on this form or relating to the voting rights or future
acquisition or disposal of any relevant
securities to which any derivative referred to on this form is
referenced. If none, this should be stated.
Is a Supplemental Form 8 attached? (Note 9) NO
Date of disclosure 6 July 2020
Contact name Nicole Napolitano
=========================
Telephone number +1 (212) 915-8098
=========================
Name of offeree/offeror Willis Towers Watson plc
with which acting in concert
=========================
Specify category and nature Director
of acting in concert status
=========================
Ap9
APPIX 3
DISCLOSURE FORMS
FORM 8.1(a)&(b)(i)
IRISH TAKEOVER PANEL
DISCLOSURE UNDER RULE 8.1(a) AND (b)(i) OF THE IRISH TAKEOVER
PANEL ACT, 1997, TAKEOVER RULES, 2013
DEALINGS BY OFFERORS, OFFEREES OR PARTIES ACTING IN CONCERT WITH
THEM FOR THEMSELVES OR FOR DISCRETIONARY CLIENTS
5. KEY INFORMATION
Name of person dealing Wendy E. Lane
(Note 1)
Company dealt in Willis Towers Watson plc
================================
Class of relevant security Ordinary Shares of $0.000304635
to which the dealings each
being disclosed relate
(Note 2)
================================
Date of dealing 10 June 2020
================================
6. INTERESTS AND SHORT POSITIONS
(c) Interests and short positions (following dealing) in the
class of relevant
security dealt in (Note 3)
Long Short
Number (%) Number (%)
============= ====== =========== ======
(1) Relevant securities Ordinary Shares:
6,916 (0.0053%)
===================== ===================
(2) Derivatives (other N/A
than options)
===================== ===================
(3) Options and agreements RSU: 803 (0.0006%)
to purchase/sell
===================== ===================
Total 7,719 (0.0059%)
===================== ===================
(d) Interests and short positions in relevant securities of the
company, other than the class dealt
in (Note 3)
Class of relevant security: Long Short
Number (%) Number (%)
=========== ===== =========== ======
(1) Relevant securities N/A
==================== =====================
N/A
(2) Derivatives (other
than options)
==================== =====================
N/A
(3) Options and agreements
to purchase/sell
==================== =====================
Total N/A
==================== =====================
Ap10
7. DEALINGS (Note 4)
(e) Purchases and sales
Purchase/sale Number of relevant securities Price per unit
(Note 5)
(f) Derivatives transactions (other than options transactions)
Product Nature of transaction Number of relevant Price per
name, (Note 6) securities unit
e.g. CFD (Note 7) (Note 5)
(g) Options transactions in respect of existing relevant securities
(iii) Writing, selling, purchasing or varying
Product Writing, Number of Exercise Type, Expiry Option
name, selling, securities price e.g. American, date money paid/received
e.g. call purchasing, to which European per unit
option varying the option etc. (Note 5)
etc. relates (Note
7)
RSU Grant 803 N/A N/A N/A N/A
============= =============== ========= ================ ====== =====================
(iv) Exercising
Product name, Number of securities Exercise price
e.g. call option per unit (Note
5)
(h) Other dealings (including transactions in respect of new
securities) (Note 4)
Nature of transaction Details Price per unit
(Note 8) (if applicable)
(Note 5)
Ap11
8. OTHER INFORMATION
Agreements, arrangements or understandings relating to options
or derivatives
Full details of any agreement, arrangement or understanding
between the person disclosing and any
other person relating to the voting rights of any relevant
securities under any option referred to on this
form or relating to the voting rights or future acquisition or
disposal of any relevant
securities to which any derivative referred to on this form is
referenced. If none, this should be stated.
Is a Supplemental Form 8 attached? (Note 9) NO
Date of disclosure 6 July 2020
Contact name Nicole Napolitano
=========================
Telephone number +1 (212) 915-8098
=========================
Name of offeree/offeror Willis Towers Watson plc
with which acting in concert
=========================
Specify category and nature Director
of acting in concert status
=========================
Ap9
APPIX 3
DISCLOSURE FORMS
FORM 8.1(a)&(b)(i)
IRISH TAKEOVER PANEL
DISCLOSURE UNDER RULE 8.1(a) AND (b)(i) OF THE IRISH TAKEOVER
PANEL ACT, 1997, TAKEOVER RULES, 2013
DEALINGS BY OFFERORS, OFFEREES OR PARTIES ACTING IN CONCERT WITH
THEM FOR THEMSELVES OR FOR DISCRETIONARY CLIENTS
9. KEY INFORMATION
Name of person dealing Anna C. Catalano
(Note 1)
Company dealt in Willis Towers Watson plc
================================
Class of relevant security Ordinary Shares of $0.000304635
to which the dealings each
being disclosed relate
(Note 2)
================================
Date of dealing 10 June 2020
================================
10. INTERESTS AND SHORT POSITIONS
(e) Interests and short positions (following dealing) in the
class of relevant
security dealt in (Note 3)
Long Short
Number (%) Number (%)
============= ======= =========== ======
(1) Relevant securities Ordinary Shares:
5,244(0.0040%)
====================== ===================
(2) Derivatives (other N/A
than options)
====================== ===================
(3) Options and agreements RSU: 803 (0.00062%)
to purchase/sell
====================== ===================
Total 6,047(0.0046%)
====================== ===================
(f) Interests and short positions in relevant securities of the
company, other than the class dealt
in (Note 3)
Class of relevant security: Long Short
Number (%) Number (%)
=========== ===== =========== ======
(1) Relevant securities N/A
==================== =====================
N/A
(2) Derivatives (other
than options)
==================== =====================
N/A
(3) Options and agreements
to purchase/sell
==================== =====================
Total N/A
==================== =====================
Ap10
11. DEALINGS (Note 4)
(i) Purchases and sales
Purchase/sale Number of relevant securities Price per unit
(Note 5)
(j) Derivatives transactions (other than options transactions)
Product Nature of transaction Number of relevant Price per
name, (Note 6) securities unit
e.g. CFD (Note 7) (Note 5)
(k) Options transactions in respect of existing relevant securities
(v) Writing, selling, purchasing or varying
Product Writing, Number of Exercise Type, Expiry Option
name, selling, securities price e.g. American, date money paid/received
e.g. call purchasing, to which European per unit
option varying the option etc. (Note 5)
etc. relates (Note
7)
RSU Grant 803 N/A N/A N/A N/A
============= =============== ========= ================ ====== =====================
(vi) Exercising
Product name, Number of securities Exercise price
e.g. call option per unit (Note
5)
(l) Other dealings (including transactions in respect of new
securities) (Note 4)
Nature of transaction Details Price per unit
(Note 8) (if applicable)
(Note 5)
Ap11
12. OTHER INFORMATION
Agreements, arrangements or understandings relating to options
or derivatives
Full details of any agreement, arrangement or understanding
between the person disclosing and any
other person relating to the voting rights of any relevant
securities under any option referred to on this
form or relating to the voting rights or future acquisition or
disposal of any
relevant securities to which any derivative referred to on this
form is referenced. If none, this should be stated.
Is a Supplemental Form 8 attached? (Note 9) NO
Date of disclosure 6 July 2020
Contact name Nicole Napolitano
=========================
Telephone number +1 (212) 915-8098
=========================
Name of offeree/offeror Willis Towers Watson plc
with which acting in concert
=========================
Specify category and nature Director
of acting in concert status
=========================
Ap9
APPIX 3
DISCLOSURE FORMS
FORM 8.1(a)&(b)(i)
IRISH TAKEOVER PANEL
DISCLOSURE UNDER RULE 8.1(a) AND (b)(i) OF THE IRISH TAKEOVER
PANEL ACT, 1997, TAKEOVER RULES, 2013
DEALINGS BY OFFERORS, OFFEREES OR PARTIES ACTING IN CONCERT WITH
THEM FOR THEMSELVES OR FOR DISCRETIONARY CLIENTS
13. KEY INFORMATION
Name of person dealing Linda D. Rabbitt
(Note 1)
Company dealt in Willis Towers Watson plc
================================
Class of relevant security Ordinary Shares of $0.000304635
to which the dealings each
being disclosed relate
(Note 2)
================================
Date of dealing 10 June 2020
================================
14. INTERESTS AND SHORT POSITIONS
(g) Interests and short positions (following dealing) in the
class of relevant
security dealt in (Note 3)
Long Short
Number (%) Number (%)
============= ====== =========== ======
(1) Relevant securities Ordinary Shares:
12,996(0.010%)
===================== ===================
(2) Derivatives (other N/A
than options)
===================== ===================
(3) Options and agreements RSU:803 (0.00062%)
to purchase/sell
===================== ===================
Total 13,799(0.0107%)
===================== ===================
(h) Interests and short positions in relevant securities of the
company, other than the class dealt
in (Note 3)
Class of relevant security: Long Short
Number (%) Number (%)
=========== ===== =========== ======
(1) Relevant securities N/A
==================== =====================
N/A
(2) Derivatives (other
than options)
==================== =====================
N/A
(3) Options and agreements
to purchase/sell
==================== =====================
Total N/A
==================== =====================
Ap10
15. DEALINGS (Note 4)
(m) Purchases and sales
Purchase/sale Number of relevant securities Price per unit
(Note 5)
(n) Derivatives transactions (other than options transactions)
Product Nature of transaction Number of relevant Price per
name, (Note 6) securities unit
e.g. CFD (Note 7) (Note 5)
(o) Options transactions in respect of existing relevant securities
(vii) Writing, selling, purchasing or varying
Product Writing, Number of Exercise Type, Expiry Option
name, selling, securities price e.g. American, date money paid/received
e.g. call purchasing, to which European per unit
option varying the option etc. (Note 5)
etc. relates (Note
7)
RSU Grant 803 N/A N/A N/A N/A
============= =============== ========= ================ ====== =====================
(viii) Exercising
Product name, Number of securities Exercise price
e.g. call option per unit (Note
5)
(p) Other dealings (including transactions in respect of new
securities) (Note 4)
Nature of transaction Details Price per unit
(Note 8) (if applicable)
(Note 5)
Ap11
16. OTHER INFORMATION
Agreements, arrangements or understandings relating to options
or derivatives
Full details of any agreement, arrangement or understanding
between the person disclosing and any
other person relating to the voting rights of any relevant
securities under any option referred to on this
form or relating to the voting rights or future acquisition or
disposal of any relevant
securities to which any derivative referred to on this form is
referenced. If none, this should be stated.
Is a Supplemental Form 8 attached? (Note 9) NO
Date of disclosure 6 July 2020
Contact name Nicole Napolitano
=========================
Telephone number +1 (212) 915-8098
=========================
Name of offeree/offeror Willis Towers Watson plc
with which acting in concert
=========================
Specify category and nature Director
of acting in concert status
=========================
Ap9
APPIX 3
DISCLOSURE FORMS
FORM 8.1(a)&(b)(i)
IRISH TAKEOVER PANEL
DISCLOSURE UNDER RULE 8.1(a) AND (b)(i) OF THE IRISH TAKEOVER
PANEL ACT, 1997, TAKEOVER RULES, 2013
DEALINGS BY OFFERORS, OFFEREES OR PARTIES ACTING IN CONCERT WITH
THEM FOR THEMSELVES OR FOR DISCRETIONARY CLIENTS
17. KEY INFORMATION
Name of person dealing Wilhelm Zeller
(Note 1)
Company dealt in Willis Towers Watson plc
================================
Class of relevant security Ordinary Shares of $0.000304635
to which the dealings each
being disclosed relate
(Note 2)
================================
Date of dealing 10 June 2020
================================
18. INTERESTS AND SHORT POSITIONS
(i) Interests and short positions (following dealing) in the
class of relevant
security dealt in (Note 3)
Long Short
Number (%) Number (%)
=========== ===== =========== ======
(1) Relevant securities Ordinary Shares:
7,726 (0.006%)
================== ===================
(2) Derivatives (other N/A
than options)
================== ===================
(3) Options and agreements RSU: 1,431
to purchase/sell (0.001%)
================== ===================
Total 9,157 (0.007%)
================== ===================
(j) Interests and short positions in relevant securities of the
company, other than the class dealt
in (Note 3)
Class of relevant security: Long Short
Number (%) Number (%)
=========== ===== =========== ======
(1) Relevant securities N/A
==================== =====================
N/A
(2) Derivatives (other
than options)
==================== =====================
N/A
(3) Options and agreements
to purchase/sell
==================== =====================
Total N/A
==================== =====================
Ap10
19. DEALINGS (Note 4)
(q) Purchases and sales
Purchase/sale Number of relevant securities Price per unit
(Note 5)
(r) Derivatives transactions (other than options transactions)
Product Nature of transaction Number of relevant Price per
name, (Note 6) securities unit
e.g. CFD (Note 7) (Note 5)
(s) Options transactions in respect of existing relevant securities
(ix) Writing, selling, purchasing or varying
Product Writing, Number of Exercise Type, Expiry Option
name, selling, securities price e.g. American, date money paid/received
e.g. call purchasing, to which European per unit
option varying the option etc. (Note 5)
etc. relates (Note
7)
RSU Grant 1,431 N/A N/A N/A N/A
============= =============== ========= ================ ====== =====================
(x) Exercising
Product name, Number of securities Exercise price
e.g. call option per unit (Note
5)
(t) Other dealings (including transactions in respect of new
securities) (Note 4)
Nature of transaction Details Price per unit
(Note 8) (if applicable)
(Note 5)
Ap11
20. OTHER INFORMATION
Agreements, arrangements or understandings relating to options
or derivatives
Full details of any agreement, arrangement or understanding
between the person disclosing and any
other person relating to the voting rights of any relevant
securities under any option referred to on
this form or relating to the voting rights or future acquisition
or disposal of any relevant
securities to which any derivative referred to on this form is
referenced. If none, this should be stated.
Is a Supplemental Form 8 attached? (Note 9) NO
Date of disclosure 6 July 2020
Contact name Nicole Napolitano
=========================
Telephone number +1 (212) 915-8098
=========================
Name of offeree/offeror Willis Towers Watson plc
with which acting in concert
=========================
Specify category and nature Director
of acting in concert status
=========================
Ap9
APPIX 3
DISCLOSURE FORMS
FORM 8.1(a)&(b)(i)
IRISH TAKEOVER PANEL
DISCLOSURE UNDER RULE 8.1(a) AND (b)(i) OF THE IRISH TAKEOVER
PANEL ACT, 1997, TAKEOVER RULES, 2013
DEALINGS BY OFFERORS, OFFEREES OR PARTIES ACTING IN CONCERT WITH
THEM FOR THEMSELVES OR FOR DISCRETIONARY CLIENTS
21. KEY INFORMATION
Name of person dealing Brendan R. O'Neill
(Note 1)
Company dealt in Willis Towers Watson plc
================================
Class of relevant security Ordinary Shares of $0.000304635
to which the dealings each
being disclosed relate
(Note 2)
================================
Date of dealing 10 June 2020
================================
22. INTERESTS AND SHORT POSITIONS
(k) Interests and short positions (following dealing) in the
class of relevant
security dealt in (Note 3)
Long Short
Number (%) Number (%)
============= ======= =========== ======
(1) Relevant securities Ordinary Shares:
12,309 (0.0095%)
====================== ===================
(2) Derivatives (other N/A
than options)
====================== ===================
(3) Options and agreements RSU: 803 (0.00062%)
to purchase/sell
====================== ===================
Total 13,112 (0.0101%)
====================== ===================
(l) Interests and short positions in relevant securities of the
company, other than the class dealt
in (Note 3)
Class of relevant security: Long Short
Number (%) Number (%)
=========== ===== =========== ======
(1) Relevant securities N/A
==================== =====================
N/A
(2) Derivatives (other
than options)
==================== =====================
N/A
(3) Options and agreements
to purchase/sell
==================== =====================
Total N/A
==================== =====================
Ap10
23. DEALINGS (Note 4)
(u) Purchases and sales
Purchase/sale Number of relevant securities Price per unit
(Note 5)
(v) Derivatives transactions (other than options transactions)
Product Nature of transaction Number of relevant Price per
name, (Note 6) securities unit
e.g. CFD (Note 7) (Note 5)
(w) Options transactions in respect of existing relevant securities
(xi) Writing, selling, purchasing or varying
Product Writing, Number of Exercise Type, Expiry Option
name, selling, securities price e.g. American, date money paid/received
e.g. call purchasing, to which European per unit
option varying the option etc. (Note 5)
etc. relates (Note
7)
RSU Grant 803 N/A N/A N/A N/A
============= =============== ========= ================ ====== =====================
(xii) Exercising
Product name, Number of securities Exercise price
e.g. call option per unit (Note
5)
(x) Other dealings (including transactions in respect of new
securities) (Note 4)
Nature of transaction Details Price per unit
(Note 8) (if applicable)
(Note 5)
Ap11
24. OTHER INFORMATION
Agreements, arrangements or understandings relating to options
or derivatives
Full details of any agreement, arrangement or understanding
between the person disclosing and
any other person relating to the voting rights of any relevant
securities under any option referred
to on this form or relating to the voting rights or future
acquisition or disposal
of any
relevant securities to which any derivative referred to on this
form is referenced. If none, this should be stated.
Is a Supplemental Form 8 attached? (Note 9) NO
Date of disclosure 6 July 2020
Contact name Nicole Napolitano
=========================
Telephone number +1 (212) 915-8098
=========================
Name of offeree/offeror Willis Towers Watson plc
with which acting in concert
=========================
Specify category and nature Director
of acting in concert status
=========================
Ap9
APPIX 3 DISCLOSURE FORMS
FORM 8.1(a)&(b)(i)
IRISH TAKEOVER PANEL
DISCLOSURE UNDER RULE 8.1(a) AND (b)(i) OF THE IRISH TAKEOVER
PANEL ACT, 1997, TAKEOVER RULES, 2013
DEALINGS BY OFFERORS, OFFEREES OR PARTIES ACTING IN CONCERT WITH
THEM FOR THEMSELVES OR FOR DISCRETIONARY CLIENTS
25. KEY INFORMATION
Name of person dealing Victor Ganzi
(Note 1)
Company dealt in Willis Towers Watson plc
================================
Class of relevant security Ordinary Shares of $0.000304635
to which the dealings each
being disclosed relate
(Note 2)
================================
Date of dealing 10 June 2020
================================
26. INTERESTS AND SHORT POSITIONS
(m) Interests and short positions (following dealing) in the
class of relevant
security dealt in (Note 3)
Long Short
Number (%) Number (%)
=========== ====== =========== ======
(1) Relevant securities Ordinary Shares:
19,251 (0.0149%)
=================== ===================
(2) Derivatives (other N/A
than options)
=================== ===================
(3) Options and agreements RSU: 2,184
to purchase/sell (0.0016%)
=================== ===================
Total 21,435 (0.0166%)
=================== ===================
(n) Interests and short positions in relevant securities of the
company, other than the class dealt
in (Note 3)
Class of relevant security: Long Short
Number (%) Number (%)
=========== ===== =========== ======
(1) Relevant securities
==================== =====================
(2) Derivatives (other
than options)
==================== =====================
(3) Options and agreements
to purchase/sell
==================== =====================
Total
==================== =====================
Ap10
27. DEALINGS (Note 4)
(y) Purchases and sales
Purchase/sale Number of relevant securities Price per unit
(Note 5)
(z) Derivatives transactions (other than options transactions)
Product Nature of transaction Number of relevant Price per
name, (Note 6) securities unit
e.g. CFD (Note 7) (Note 5)
(aa) Options transactions in respect of existing relevant securities
(xiii) Writing, selling, purchasing or varying
Product Writing, Number of Exercise Type, Expiry Option
name, selling, securities price e.g. American, date money paid/received
e.g. call purchasing, to which European per unit
option varying the option etc. (Note 5)
etc. relates (Note
7)
RSU Grant 2,184 N/A N/A N/A N/A
============= =============== ========= ================ ====== =====================
(xiv) Exercising
Product name, Number of securities Exercise price
e.g. call option per unit (Note
5)
(bb) Other dealings (including transactions in respect of new
securities) (Note 4)
Nature of transaction Details Price per unit
(Note 8) (if applicable)
(Note 5)
Ap11
28. OTHER INFORMATION
Agreements, arrangements or understandings relating to options
or derivatives
Full details of any agreement, arrangement or understanding
between the person disclosing and
any other person relating to the voting rights of any relevant
securities under any option referred
to on this form or relating to the voting rights or future
acquisition or disposal
of any
relevant securities to which any derivative referred to on this
form is referenced. If none, this should be stated.
Is a Supplemental Form 8 attached? (Note 9) NO
Date of disclosure 6 July 2020
Contact name Nicole Napolitano
=========================
Telephone number +1 (212) 915-8098
=========================
Name of offeree/offeror Willis Towers Watson plc
with which acting in concert
=========================
Specify category and nature Director
of acting in concert status
=========================
Ap9
APPENDIX 3
DISCLOSURE FORMS
FORM 8.1(a)&(b)(i)
IRISH TAKEOVER PANEL
DISCLOSURE UNDER RULE 8.1(a) AND (b)(i) OF THE IRISH TAKEOVER
PANEL ACT, 1997, TAKEOVER RULES, 2013
DEALINGS BY OFFERORS, OFFEREES OR PARTIES ACTING IN CONCERT WITH
THEM FOR THEMSELVES OR FOR DISCRETIONARY CLIENTS
29. KEY INFORMATION
Name of person dealing Paul Thomas
(Note 1)
Company dealt in Willis Towers Watson plc
================================
Class of relevant security Ordinary Shares of $0.000304635
to which the dealings each
being disclosed relate
(Note 2)
================================
Date of dealing 10 June 2020
================================
30. INTERESTS AND SHORT POSITIONS
(o) Interests and short positions (following dealing) in the
class of relevant
security dealt in (Note 3)
Long Short
Number (%) Number (%)
============= ======= =========== ======
(1) Relevant securities Ordinary Shares:
10,222 (0.0079%)
====================== ===================
(2) Derivatives (other N/A
than options)
====================== ===================
(3) Options and agreements RSU: 803 (0.00062%)
to purchase/sell
====================== ===================
Total 11,025 (0.0085%)
====================== ===================
(p) Interests and short positions in relevant securities of the
company, other than the class dealt
in (Note 3)
Class of relevant security: Long Short
Number (%) Number (%)
=========== ===== =========== ======
(1) Relevant securities N/A
==================== =====================
N/A
(2) Derivatives (other
than options)
==================== =====================
N/A
(3) Options and agreements
to purchase/sell
==================== =====================
Total N/A
==================== =====================
Ap10
31. DEALINGS (Note 4)
(cc) Purchases and sales
Purchase/sale Number of relevant securities Price per unit
(Note 5)
(dd) Derivatives transactions (other than options transactions)
Product Nature of transaction Number of relevant Price per
name, (Note 6) securities unit
e.g. CFD (Note 7) (Note 5)
(ee) Options transactions in respect of existing relevant securities
(xv) Writing, selling, purchasing or varying
Product Writing, Number of Exercise Type, Expiry Option
name, selling, securities price e.g. American, date money paid/received
e.g. call purchasing, to which European per unit
option varying the option etc. (Note 5)
etc. relates (Note
7)
RSU Grant 803 N/A N/A N/A N/A
============= =============== ========= ================ ====== =====================
(xvi) Exercising
Product name, Number of securities Exercise price
e.g. call option per unit (Note
5)
(ff) Other dealings (including transactions in respect of new
securities) (Note 4)
Nature of transaction Details Price per unit
(Note 8) (if applicable)
(Note 5)
Ap11
32. OTHER INFORMATION
Agreements, arrangements or understandings relating to options
or derivatives
Full details of any agreement, arrangement or understanding
between the person disclosing and
any other person relating to the voting rights of any relevant
securities under any option referred to
on this form or relating to the voting rights or future
acquisition or disposal of any relevant
securities to which any derivative referred to on this form is
referenced. If none, this should be stated.
Is a Supplemental Form 8 attached? (Note 9) NO
Date of disclosure 6 July 2020
Contact name Nicole Napolitano
=========================
Telephone number +1 (212) 915-8098
=========================
Name of offeree/offeror Willis Towers Watson plc
with which acting in concert
=========================
Specify category and nature Director
of acting in concert status
=========================
This information is provided by RNS, the news service of the
London Stock Exchange. RNS is approved by the Financial Conduct
Authority to act as a Primary Information Provider in the United
Kingdom. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact rns@lseg.com or visit www.rns.com.
END
ISEUPUACMUPUGQQ
(END) Dow Jones Newswires
July 06, 2020 12:53 ET (16:53 GMT)
Willis Towers Watson (LSE:0Y4Q)
Gráfica de Acción Histórica
De Mar 2024 a Abr 2024
Willis Towers Watson (LSE:0Y4Q)
Gráfica de Acción Histórica
De Abr 2023 a Abr 2024
